Emergent Bio's smallpox vaccine gets US approval for mpox

Go back to Emergent Bio's smallpox vaccine gets US approval for mpox
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 6.00 +0.03 (0.50%)
Previous Close $5.97    52 Week High $44.38 
Open $5.98    52 Week Low $24.47 
Day High $6.01    P/E 300.00 
Day Low $5.75    EPS $0.02 
Volume 804,032